• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽(VIP)的C末端部分对于受体结合和激活很重要,这一点已通过VIP/促胰液素的嵌合构建体得到证实。

The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin.

作者信息

Wulff B, Møller Knudsen S, Adelhorst K, Fahrenkrug J

机构信息

Department of Molecular Pharmacology, Novo-Nordisk Park, Måløv, Denmark.

出版信息

FEBS Lett. 1997 Aug 25;413(3):405-8. doi: 10.1016/s0014-5793(97)00942-3.

DOI:10.1016/s0014-5793(97)00942-3
PMID:9303545
Abstract

The structural requirements of vasoactive intestinal polypeptide (VIP) for receptor binding and cAMP production were studied in a cell line stable transfected with the cDNA for rat VIP receptor 1 (rVIPR 1). Using a number of chimeric constructs of VIP and the homologue peptide secretin, it was found that the N-terminal half of VIP (1-11) can be exchanged with the corresponding sequences in secretin with only modest influence on binding and activation, whereas the opposite chimeras with N-terminal VIP and C-terminal secretin were unable to bind to the VIP receptor. The data suggest that the C-terminal region of VIP is important for receptor binding and activation.

摘要

利用稳定转染大鼠血管活性肠肽受体1(rVIPR 1)cDNA的细胞系,研究了血管活性肠肽(VIP)与受体结合及产生环磷酸腺苷(cAMP)的结构要求。使用多种VIP与同源肽促胰液素的嵌合构建体,发现VIP的N端一半(1-11)可与促胰液素中的相应序列交换,对结合和激活的影响较小,而N端为VIP、C端为促胰液素的反向嵌合体则无法与VIP受体结合。数据表明,VIP的C端区域对受体结合和激活很重要。

相似文献

1
The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin.血管活性肠肽(VIP)的C末端部分对于受体结合和激活很重要,这一点已通过VIP/促胰液素的嵌合构建体得到证实。
FEBS Lett. 1997 Aug 25;413(3):405-8. doi: 10.1016/s0014-5793(97)00942-3.
2
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides. 1996;17(5):825-9. doi: 10.1016/0196-9781(96)00107-6.
3
Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin binding.人血管活性肠肽1型受体选择性过滤器。确定限制促胰液素结合的关键结构域。
J Biol Chem. 2002 Oct 4;277(40):37016-22. doi: 10.1074/jbc.M203049200. Epub 2002 Jul 19.
4
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.促胰液素8-15位氨基酸残基与促胰液素受体N端结构域的相互作用。
Eur J Biochem. 1996 Jul 15;239(2):349-55. doi: 10.1111/j.1432-1033.1996.0349u.x.
5
Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.大鼠促胰液素受体的序列(103 - 110)和(116 - 120)与促胰液素和血管活性肠肽的识别有关。
Ann N Y Acad Sci. 2000;921:362-5. doi: 10.1111/j.1749-6632.2000.tb06994.x.
6
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.血管活性肠肽(VIP)、蛙皮素和垂体腺苷酸环化酶激活肽(PACAP)的类似物可区分大鼠和人类的VIP1和VIP2受体。
Ann N Y Acad Sci. 1998 Dec 11;865:247-52. doi: 10.1111/j.1749-6632.1998.tb11184.x.
7
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.
Biochem Biophys Res Commun. 1995 Jun 26;211(3):885-91. doi: 10.1006/bbrc.1995.1895.
8
Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Ann N Y Acad Sci. 1998 Dec 11;865:386-9. doi: 10.1111/j.1749-6632.1998.tb11201.x.
9
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.不同的血管活性肠肽受体结构域参与了两种VPAC(2)选择性配体的选择性识别。
Mol Pharmacol. 1999 Dec;56(6):1280-7. doi: 10.1124/mol.56.6.1280.
10
Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.促胰液素和VPAC(1)受体激活选择性的交叉嵌合分析。
J Pharmacol Exp Ther. 2000 Nov;295(2):682-8.